Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | MGLL | Q99685 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL50263 | 0.90 | TSHR (0.48) | MGLLTSHRALOX5TDP1ALDH1A1 | |
| SCHEMBL9328711 | 0.89 | ESR1 (0.52) | ESR1ESR2MGLLTSHRALOX5 | |
| Parahydroxybenzyl Alcohol SCHEMBL27742784 | 0.87 | TSHR (0.39) | ESR1ESR2MGLLTSHRALOX5 | |
| SCHEMBL18876519 | 0.87 | TSHR (0.42) | ESR1ESR2MGLLTSHRALOX5 | |
| SCHEMBL4436621 | 0.86 | ALDH1A1 (0.42) | ESR1MGLLTSHRALOX5TDP1 | |
| SCHEMBL5078949 | 0.86 | ALDH1A1 (0.42) | ESR1MGLLTSHRALOX5TDP1 | |
| SCHEMBL12172323 | 0.85 | MGLL (0.47) | MGLLTSHRTDP1ALDH1A1TP53 | |
| SCHEMBL21863346 | 0.85 | MGLL (0.47) | MGLLTSHRTDP1ALDH1A1TP53 | |
| SCHEMBL2898358 | 0.85 | ESR1 (0.44) | ESR1ESR2MGLLTSHRTDP1 | |
| Tyrosol SCHEMBL732381 | 0.84 | CA2 (0.57) | ESR1ESR2MGLLTSHRALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030149219-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | BORIACK CLINTON J (US) | 2003-08-07 | — | — | US | claimed |
| US-20020045707-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2002-04-18 | — | — | US | claimed |
| US-12617753-B2 | Urea derivatives and their use as curatives and curative accelerators for resin systems | HEXCEL COMPOSITES LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| EP-4680659-A1 | USE OF HYDROXY SUBSTITUTED URONES AS CURE ACCELERATORS | Hexcel Composites Limited (GB) | 2026-01-21 | — | — | EP | disclosed |
| EP-3959217-B1 | IMPROVEMENTS IN OR RELATING TO CURATIVES | HEXCEL COMPOSITES LTD (GB) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024194067-A1 | USE OF HYDROXY SUBSTITUTED URONES AS CURE ACCELERATORS | HEXCEL COMPOSITES LIMITED (GB) | 2024-09-26 | — | — | WO | disclosed |
| US-20240262790-A1 | UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS | HEXCEL COMPOSITES LIMITED (GB) | 2024-08-08 | — | — | US | disclosed |
| US-11939421-B2 | Or relating to curing agents | HEXCEL COMPOSITES LIMITED (GB) | 2024-03-26 | — | — | US | disclosed |
| US-11879052-B2 | Curatives | HEXCEL COMPOSITES LIMITED (GB) | 2024-01-23 | — | — | US | disclosed |
| US-11760904-B2 | Adhesive tape | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| CN-116496748-A | Adhesive composition, adhesive layer, adhesive sheet, and adhesive tape | DIC株式会社 | 2023-07-28 | — | — | CN | disclosed |
| EP-0635528-B1 | Epoxy-modified polyamide resin | HITACHI CHEMICAL CO LTD (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-0761722-B1 | ORGANOPOLYSILOXANE DERIVATIVE | NAGASE CIBA LTD (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-20020045707-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2002-04-18 | — | — | US | disclosed |
| US-5874518-A | Epoxy-modified polyamide resin | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1999-02-23 | — | — | US | disclosed |
| US-5844053-A | Organo-polysiloxane derivartives | NAGASE-CIBA, LTD. (JP) | 1998-12-01 | — | — | US | disclosed |
| EP-0761722-A1 | ORGANOPOLYSILOXANE DERIVATIVE | Nagase-Ciba Ltd. (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0635528-A2 | Epoxy-modified polyamide resin | Hitachi Chemical Co., Ltd. (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5229485-A | From pyromellitic acid and aromatic diamine, optionally terminated with aminophenol or allylnadic acid; tougheners | CIBA-GEIGY CORPORATION (US) | 1993-07-20 | — | — | US | disclosed |
| US-4826927-A | LAMINATING RESINS, ELECTRO-RESINS | CIBA-GEIGY CORPORATION (US) | 1989-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617753-B2 | Urea derivatives and their use as curatives and curative accelerators for resin systems | UTS2R, UPP1, XDH | ESR1 1985/4885ESR2 2089/4885MGLL 2106/4885 |
| US-11939421-B2 | Or relating to curing agents | FABP4, RARA, ADIPOR1 | ESR1 1730/4885ESR2 1873/4885MGLL 723/4885 |
| US-20240262790-A1 | UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS | UMPS, UTS2R, UNG | ESR1 793/4885ESR2 1145/4885MGLL 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.